On-Demand Webinar Request Form: Comprehensive Genomic Profiling using the Oncomine Comprehensive Assay Plus System

View our free, on-demand webinar series to learn about the Oncomine Comprehensive Assay Plus

Precision oncology research continues to explore the utility of targeted therapies and immunotherapies. As we gain a deeper understanding of the molecular mechanisms of tumor biology, comprehensive genomic profiling (CGP) is critical to help drive insights into advancing the future of personalized medicine. In this webinar series, learn how the Ion Torrent Oncomine Comprehensive Assay Plus, an amplicon-based next-generation sequencing (NGS) assay, can be used to simultaneously analyze a broad range of biomarkers, including homologous recombination deficiency (HRD), in one test to maximize insights into the underlying oncogenic drivers in timely manner.

Multicenter study of the Oncomine Comprehensive Assay Plus for local comprehensive molecular profiling

Speaker: Dr. Eloisa Jantus Lewintre, PhD, Associate Professor of Cell Biology, Polytechnic University of Valencia, Spain

Future clinical perspective of HRD testing in ovarian cancer samples using NGS CGP

Speakers: Dr. Nicola Normanno, MD, Director, Translational Research, National Cancer Institute, Italy - Pascale Foundation and Dr. Philip Jermann, PhD, Clinical Director, Medical Affairs, Clinical Sequencing, Thermo Fisher Scientific

Genomic Instability Metric (GIM) from Oncomine Comprehensive Assay Plus

Speakers: Dr. Annette Staebler, MD, Head of Gynecological Pathology and Mammary Pathology Division, University Hospital Tübingen, Germany

(*Indicates a mandatory field)

First name*

Last name*

Institution*

City*

Country/Region*

Email*

Would you like a representative to provide you with a quote or demo of the Oncomine Comprehensive Assay Plus system?*

Yes

Would you like a representative to provide you with demo and/or pricing information for Ion Torrent NGS System?*

Yes

For Research Use Only. Not for use in diagnostic procedures.